Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System

NCT: NCT07092761 · RECRUITING

NCT IDNCT07092761
StatusRECRUITING
Start Date2025-04-01
Completion2026-09-01

Brief Summary

The study is to evaluate the accuracy and safety of a novel real-time CGM system among adult patients with type 1 diabetes mellitus with respect to YSI reference venous plasma sample measurements.

Frequently Asked Questions

What is Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System?

Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System is a clinical trial registered under NCT07092761. Current status: RECRUITING.

What is the status of NCT07092761?

The current status of NCT07092761 (Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System) is: RECRUITING.

When did Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System start?

Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System started on 2025-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑